Keybank National Association Boston Scientific Corp Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Boston Scientific Corp stock. As of the latest transaction made, Keybank National Association holds 15,453 shares of BSX stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

15,453

Previous 14,585 5.95%

Holding current value

$1.39 Million

Previous $1.12 Million 15.23%

% of portfolio

0.01%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$72.96 - $84.0 $63,329 - $72,912	868 Added 5.95%	15,453 $1.29 Million
Q2 2024 Jul 31, 2024	BUY	$67.33 - $77.71 $46,323 - $53,464	688 Added 4.95%	14,585 $1.12 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $44,179 - $52,631	767 Added 5.84%	13,897 $951,000
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $217,907 - $258,988	-4,480 Reduced 25.44%	13,130 $759,000
Q3 2023 Nov 08, 2023	BUY	$50.19 - $54.68 $263,949 - $287,562	5,259 Added 42.58%	17,610 $929,000
Q2 2023 Aug 01, 2023	SELL	$49.72 - $54.64 $117,985 - $129,660	-2,373 Reduced 16.12%	12,351 $668,000
Q1 2023 May 10, 2023	BUY	$45.09 - $50.03 $100,866 - $111,917	2,237 Added 17.91%	14,724 $736,000
Q4 2022 Jan 31, 2023	BUY	$39.56 - $47.22 $56,966 - $67,996	1,440 Added 13.04%	12,487 $577,000
Q3 2022 Oct 27, 2022	BUY	$36.71 - $109.66 $734 - $2,193	20 Added 0.18%	11,047 $428,000
Q2 2022 Aug 08, 2022	SELL	$35.24 - $47.1 $16,950 - $22,655	-481 Reduced 4.18%	11,027 $411,000
Q1 2022 Apr 28, 2022	BUY	$40.9 - $45.1 $44,621 - $49,204	1,091 Added 10.47%	11,508 $510,000
Q4 2021 Feb 07, 2022	SELL	$38.07 - $44.87 $59,579 - $70,221	-1,565 Reduced 13.06%	10,417 $443,000
Q3 2021 Nov 08, 2021	BUY	$41.23 - $45.88 $103,817 - $115,525	2,518 Added 26.61%	11,982 $520,000
Q2 2021 Aug 12, 2021	BUY	$38.58 - $44.24 $53,896 - $61,803	1,397 Added 17.32%	9,464 $405,000
Q1 2021 May 07, 2021	BUY	$35.27 - $39.67 $28,568 - $32,132	810 Added 11.16%	8,067 $312,000
Q4 2020 Feb 09, 2021	BUY	$33.15 - $41.97 $17,072 - $21,614	515 Added 7.64%	7,257 $261,000
Q3 2020 Oct 29, 2020	SELL	$34.44 - $42.23 $185,218 - $227,112	-5,378 Reduced 44.37%	6,742 $258,000
Q2 2020 Aug 10, 2020	SELL	$30.19 - $39.11 $9,992 - $12,945	-331 Reduced 2.66%	12,120 $426,000
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $19,062 - $33,733	-738 Reduced 5.6%	12,451 $406,000
Q4 2019 Feb 05, 2020	BUY	$37.87 - $45.37 $10,073 - $12,068	266 Added 2.06%	13,189 $596,000
Q3 2019 Nov 04, 2019	SELL	$40.31 - $43.45 $31,441 - $33,891	-780 Reduced 5.69%	12,923 $526,000
Q2 2019 Aug 01, 2019	SELL	$34.91 - $42.98 $8,552 - $10,530	-245 Reduced 1.76%	13,703 $589,000
Q1 2019 May 08, 2019	SELL	$32.91 - $40.75 $41,236 - $51,059	-1,253 Reduced 8.24%	13,948 $535,000
Q4 2018 Jan 30, 2019	BUY	$31.73 - $39.04 $35,093 - $43,178	1,106 Added 7.85%	15,201 $537,000
Q3 2018 Nov 08, 2018	SELL	$32.83 - $38.63 $83,618 - $98,390	-2,547 Reduced 15.3%	14,095 $543,000
Q2 2018 Aug 08, 2018	BUY	$26.84 - $34.32 $94,154 - $120,394	3,508 Added 26.71%	16,642 $544,000
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $45,284 - $51,286	-1,797 Reduced 12.04%	13,134 $359,000
Q4 2017 Feb 08, 2018	SELL	$24.79 - $29.8 $322,914 - $388,174	-13,026 Reduced 46.59%	14,931 $370,000
Q3 2017 Nov 02, 2017	SELL	$26.26 - $29.17 $20,876 - $23,190	-795 Reduced 2.77%	27,957 $816,000
Q2 2017 May 14, 2018	BUY	N/A	1,277 Added 4.65%	28,752 $797,000
Q1 2017 May 14, 2018	BUY	N/A	2,805 Added 11.37%	27,475 $683,000
Q4 2016 May 14, 2018	BUY	N/A	24,670	24,670 $534,000

Others Institutions Holding BSX

# of Institutions

1,542

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Boston Scientific Corp Transaction History